We are live on
!
Find out more
IP
Isthmus Partners Portfolio holdings
AUM
$1.03B
1-Year Est. Return
22.86%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+22.86%
3 Year Est. Return
+61.07%
5 Year Est. Return
+76.25%
10 Year Est. Return
+352.5%
AUM
$304M
AUM Growth
+$4.41M
(+1.5%)
Cap. Flow
-$6.35M
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
23.43%
Holding
253
New
2
Increased
22
Reduced
99
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IQVIA
IQV
|
+$5.64M |
| 2 |
BSTC
BioSpecifics Technologies Corp.
BSTC
|
+$637K |
| 3 |
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
|
+$234K |
| 4 |
IRIDEX
IRIX
|
+$175K |
| 5 |
SLB Ltd
SLB
|
+$149K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAL
Valspar
VAL
|
+$7.01M |
| 2 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$663K |
| 3 |
MASI
Masimo
MASI
|
+$615K |
| 4 |
TFM
THE FRESH MARKET, INC COM STK
TFM
|
+$561K |
| 5 |
Charles River Laboratories
CRL
|
+$290K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.45% |
| 2 | Industrials | 18.46% |
| 3 | Technology | 16.64% |
| 4 | Financials | 11.78% |
| 5 | Consumer Staples | 6.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
FMC
FMC
$1.42B
| $5.57M | 1.83% |
138,666
-1,927
| -1% | -$75.5K |
|
27
Abbott
ABT
$180B
| $5.54M | 1.82% |
140,829
+310
| +0.2% | +$12.3K |
|
|
CELG
28
DELISTED
Celgene Corp
CELG
| $5.53M | 1.82% |
56,075
-772
| -1% | -$79.9K |
|
|
29
IQVIA
IQV
$34.7B
| $5.5M | 1.81% |
+84,231
| New | +$5.64M |
|
30
C.H. Robinson
CHRW
$22B
| $5.45M | 1.79% |
73,355
-300
| -0.4% | -$21.9K |
|
|
VAR
31
DELISTED
Varian Medical Systems, Inc.
VAR
| $5.42M | 1.78% |
75,228
-729
| -1% | -$52.9K |
|
32
Flowserve
FLS
$9.25B
| $5.4M | 1.78% |
119,453
-1,512
| -1% | -$70.8K |
|
33
Rockwell Automation
ROK
$51.4B
| $5.25M | 1.73% |
45,693
-110
| -0.2% | -$12.6K |
|
34
W.W. Grainger
GWW
$65.3B
| $5.22M | 1.72% |
22,989
-84
| -0.4% | -$19.1K |
|
35
Qualcomm
QCOM
$176B
| $5.07M | 1.67% |
94,559
+308
| +0.3% | +$16.2K |
|
36
ConocoPhillips
COP
$147B
| $4.9M | 1.61% |
112,314
-2,115
| -2% | -$93.3K |
|
37
PNC Financial Services
PNC
$100B
| $4.77M | 1.57% |
58,612
-999
| -2% | -$85.9K |
|
|
SNI
38
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $4.38M | 1.44% |
70,272
-780
| -1% | -$49.8K |
|
39
PayPal
PYPL
$49.5B
| $4.32M | 1.42% |
118,364
-1,257
| -1% | -$48.1K |
|
|
MJN
40
DELISTED
Mead Johnson Nutrition Company
MJN
| $4.13M | 1.36% |
45,466
+370
| +0.8% | +$31.3K |
|
41
eBay
EBAY
$48.6B
| $3.58M | 1.18% |
153,143
+450
| +0.3% | +$10.9K |
|
42
Kohl's
KSS
$2.03B
| $3.5M | 1.15% |
92,220
+1,465
| +2% | +$58.2K |
|
43
Lincoln National
LNC
$7.91B
| $3.11M | 1.02% |
80,258
+2,422
| +3% | +$103K |
|
44
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
| $2.13M | 0.7% |
82,470
+3,552
| +5% | +$91.1K |
|
45
Freeport-McMoran
FCX
$90B
| $1.52M | 0.5% |
136,456
-8,471
| -6% | -$93.8K |
|
|
CCF
46
DELISTED
Chase Corporation
CCF
| $998K | 0.33% |
16,894
-1,239
| -7% | -$71.1K |
|
47
Universal Electronics
UEIC
$57.2M
| $995K | 0.33% |
13,764
-670
| -5% | -$44K |
|
|
VASC
48
DELISTED
Vascular Solutions Inc
VASC
| $968K | 0.32% |
23,228
-1,272
| -5% | -$47.3K |
|
49
Tennant Co
TNC
$1.5B
| $936K | 0.31% |
17,370
-101
| -0.6% | -$5.37K |
|
50
AMERISAFE
AMSF
$569M
| $915K | 0.3% |
14,948
-623
| -4% | -$35.6K |
|
Similar funds
CM
CFFNO
RIM
TBA
JSC
MGWM
MSIIA
NFG
Isthmus Partners's Q2 2016 Portfolio in Review
As of Q2 2016, Isthmus Partners held 253 positions worth $304M, up 1.5% from $300M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q2 2016: portfolio turnover was 2.8%. Isthmus Partners opened 2 new positions and exited 5, leaving the 253-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Technology.
- Isthmus Partners's largest Q2 2016 buy was IQVIA: 84,231 shares worth $5.5M.
- Isthmus Partners added most to Aralez Pharmaceuticals Inc. in Q2 2016, an estimated $234K increase.
- Isthmus Partners's biggest Q2 2016 reduction was Valspar, cutting an estimated $7.01M.
- Isthmus Partners fully exited THE FRESH MARKET, INC COM STK in Q2 2016, selling an estimated $561K.
- Isthmus Partners's ten largest holdings make up 23% of its $304M portfolio in Q2 2016.
- Isthmus Partners opened 2 new positions and closed 5 in Q2 2016.
- Isthmus Partners's portfolio value rose 1.5% quarter-over-quarter to $304M.
Based on Isthmus Partners's 13F filing for Q2 2016, filed 8 Aug 2016.